Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.30 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.30 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.30 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13798648 | 0.93 | PTPN11 (0.37) | PTPN11BRD4TP53CREBBPENPP2 | |
| SCHEMBL12191838 | 0.90 | PTPN11 (0.35) | PTPN11BRD4TP53CREBBPENPP2 | |
| SCHEMBL6123910 | 0.88 | PTPN11 (0.36) | PTPN11BRD4ENPP2 | |
| SCHEMBL6123849 | 0.87 | PTPN11 (0.40) | PTPN11BRD4TP53CREBBPENPP2 | |
| SCHEMBL6123856 | 0.86 | PTPN11 (0.33) | PTPN11 | |
| SCHEMBL6125338 | 0.84 | ENPP2 (0.41) | BRD4TP53CREBBPENPP2SUMO2 | |
| SCHEMBL13798646 | 0.84 | PTPN11 (0.31) | PTPN11 | |
| SCHEMBL12758902 | 0.82 | PTPN11 (0.32) | PTPN11 | |
| SCHEMBL6123832 | 0.81 | SENP2 (0.41) | BRD4TP53CREBBPENPP2SUMO2 | |
| SCHEMBL19958129 | 0.79 | BRD4 (0.40) | BRD4TP53CREBBPENPP2SUMO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8167991-B2 | Trisazo compound, ink composition, recording method, and colored article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | JAK1, TMT1A, CDK1 | PTPN11 344/4885BRD4 2209/4885TP53 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.